Clinical Trial

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Study acronym: DASH-Obesity
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-24
Trial Details
NCT Number NCT07638345
Lead Sponsor Adhera Health, Inc.
Conditions Type 1 Diabetes, T1D, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Asthma Acute, Asthma (Diagnosis)
Enrollment 280 participants
Start Date 2025-10-30
Primary Completion 2026-03-27 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-23